Clinical Trial News & Results
This section provides information about recently completed clinical trials. If you cannot find information about a particular clinical trial, you should note that results may not be available even after the trial ends. Some trials end before completion and results are never published.
Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease
CARLSBAD, Calif., July 18, 2024. Ionis Pharmaceuticals, Inc. announced today that it has completed enrollment in the pivotal trial of zilganersen (ION373), an...
Agenus Announces End-of-Phase-2 Meeting Outcomes and Topline Interim Phase 2 Data for Botensilimab/Balstilimab (BOT/BAL) in MSS Colorectal Cancer
LEXINGTON, Mass.--(BUSINESS WIRE) July 18, 2024 -- Agenus Inc. (NASDAQ: AGEN), a leader in developing novel immunological agents to treat various cancers...
FDA Clears Investigational New Drug application for muscular dystrophy treatment
MINNEAPOLIS and ST. PAUL, Minn., July 17, 2024. Today, Myogenica, a University of Minnesota startup company, announced U.S. Food and Drug Administration...
Evommune Announces Positive Proof-of-Concept Clinical Trial Results for its MRGPRX2 Antagonist
PALO ALTO, Calf., July 16, 2024. Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated...
Supplements Slow Disease Progression During Late Stage of "Dry" Age-Related Macular Degeneration
July 16, 2024 -- In a new analysis of data, researchers at the National Institutes of Health (NIH) have found that taking a daily supplement containing...
Genentech Announces Positive Phase I Results of Its Oral GLP-1 Receptor Agonist CT-996 for the Treatment of People With Obesity
South San Francisco, CA -- July 16, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from...
Sumitomo Pharma Announces that DSP-5336 Has Received FDA Fast Track Designation for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
MARLBOROUGH, Mass., July 15, 2024 /PRNewswire/ -- Sumitomo Pharma America, Inc. (SMPA) today announced that the U.S. Food and Drug Administration (FDA) granted...
Niclosamide-based Metabolic Anticancer Drug's First Clinical Trial Target are Prostate Cancer Patients Resistant to Hormone Therapy
SEOUL, South Korea, July 11, 2024. ADM Korea, a subsidiary of Hyundai Bioscience, announced on the 8th that the first clinical trial target population for its...
AskBio receives FDA Fast Track and MHRA Innovation Passport Designations for AB-1005 Investigational GDNF Gene Therapy for Parkinson’s Disease
Berlin, Germany, and Research Triangle Park, N.C., USA, July 11, 2024 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company...
Immunotherapy Approach Shows Potential in Some People with Metastatic Solid Tumors
July 11, 2024 -- Early findings from a small clinical trial provide evidence that a new cellular immunotherapy approach may be effective in treating metastatic...
Pfizer Advances Development of Once-Daily Formulation of Oral GLP-1 Receptor Agonist Danuglipron
NEW YORK--(BUSINESS WIRE) July 11, 2024 -- Pfizer Inc. (NYSE: PFE) today announced that based on results from the ongoing pharmacokinetic study (NCT06153758)...
Kazia Therapeutics Announces Phase II/III Clinical Trial Results for Paxalisib in Glioblastoma
SYDNEY, July 10, 2024. Kazia Therapeutics Limited, an oncology-focused drug development company, is pleased to announce results from GBM-AGILE, a phase II/III...
Expanded HyBryte Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
PRINCETON, N.J., July 9, 2024 /PRNewswire/ -- Soligenix, Inc., (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and...
Approval for the First Dose Cohort in Phase 1a/b Clinical Trial of PMC-309 in Patients with Advanced or Metastatic Solid Tumors
DAEJEON, South Korea, July 8, 2024. PharmAbcine Inc., a clinical-stage biotech company focusing on next-generation antibody therapeutics, announced that...
Genentech to Reintroduce Susvimo for People With Wet Age-Related Macular Degeneration (AMD)
South San Francisco, CA -- July 8, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the reintroduction of...
Roche provides update on phase II/III SKYSCRAPER-06 study in metastatic non-squamous non-small cell lung cancer
Basel, 04 July 2024 - Roche announced today that the phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq (atezolizumab) and chemotherapy...
Genentech Provides Update on Phase II/III Skyscraper-06 Study in Metastatic Non-Squamous Non-Small Cell Lung Cancer
South San Francisco, CA -- July 3, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III...
First Patient Dosed in Phase 2 Trial of Descartes-08 in Systematic Lupus Erythematosus
GAITHERSBURG, Md., July 02, 2024. artesian Therapeutics, Inc. (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy...
Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration Advances to Both Single-dose of 4mg and Multiple-dose of 3mg
DAEJEON, South Korea, July 2, 2024. PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next...
NIH-Sponsored Trial of Nasal COVID-19 Vaccine Opens
July 1, 2024 -- A Phase 1 trial testing the safety of an experimental nasal vaccine that may provide enhanced breadth of protection against emerging variants...
Clinical trial results archive
- 2024
- January, February, March, April, May, June, July
- 2023
- January, February, March, April, May, June, July, August, September, October, November, December
- 2022
- January, February, March, April, May, June, July, August, September, October, November, December
- 2021
- January, February, March, April, May, June, July, August, September, October, November, December
- 2020
- January, February, March, April, May, June, July, August, September, October, November, December
- 2019
- January, February, March, April, May, June, July, August, September, October, November, December
- 2018
- January, February, March, April, May, June, July, August, September, October, November, December
- 2017
- May, June, July, August, September, October, November, December
- 2016
- October
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.